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Acute and chronic exposure to hypoxia alters ventilatory pattern
but not minute ventilation of mice overexpressing erythropoietin
Abstract
Apart from enhancing red blood cell production, erythropoietin (Epo) has been shown to modulate the
ventilatory response to reduced oxygen supply. Both functions are crucial for the organism to cope with
increased oxygen demand. In the present work, we analyzed the impact of Epo and the resulting
excessive erythrocytosis in the neural control of normoxic and hypoxic ventilation. To this end, we used
our transgenic mouse line (Tg6) that shows high levels of human Epo in brain and plasma, the latter
leading to a hematocrit of approximately 80%. Interestingly, while normoxic and hypoxic ventilation in
Tg6 mice was similar to WT mice, Tg6 mice showed an increased respiratory frequency but a decreased
tidal volume. Knowing that Epo modulates catecholaminergic activity, the altered catecholaminergic
metabolism measured in brain stem suggested that the increased respiratory frequency in Tg6 mice was
related to the overexpression of Epo in brain. In the periphery, higher response to hyperoxia (Dejours
test), as well as reduced tyrosine hydroxylase activity in carotid bodies, revealed a higher
chemosensitivity to oxygen in transgenic mice. Moreover, in line with the decreased activity of the
rate-limiting enzyme for dopamine synthesis, the intraperitoneal injection of a highly specific peripheral
ventilatory stimulant, domperidone, did not stimulate hypoxic ventilatory response in Tg6 mice. These
results suggest that high Epo plasma levels modulate the carotid body's chemotransduction. All together,
these findings are relevant for understanding the cross-talk between the ventilatory and erythropoietic
systems exposed to hypoxia.
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Soliz J, Soulage C, Hermann DM, Gassmann M. Acute and
chronic exposure to hypoxia alters ventilatory pattern but not minute
ventilation of mice overexpressing erythropoietin. Am J Physiol Regul
Integr Comp Physiol 293: R1702–R1710, 2007. First published July
25, 2007; doi:10.1152/ajpregu.00350.2007.—Apart from enhancing
red blood cell production, erythropoietin (Epo) has been shown to
modulate the ventilatory response to reduced oxygen supply. Both
functions are crucial for the organism to cope with increased oxygen
demand. In the present work, we analyzed the impact of Epo and the
resulting excessive erythrocytosis in the neural control of normoxic
and hypoxic ventilation. To this end, we used our transgenic mouse
line (Tg6) that shows high levels of human Epo in brain and plasma,
the latter leading to a hematocrit of 80%. Interestingly, while
normoxic and hypoxic ventilation in Tg6 mice was similar to WT
mice, Tg6 mice showed an increased respiratory frequency but a
decreased tidal volume. Knowing that Epo modulates catecholamin-
ergic activity, the altered catecholaminergic metabolism measured in
brain stem suggested that the increased respiratory frequency in Tg6
mice was related to the overexpression of Epo in brain. In the
periphery, higher response to hyperoxia (Dejours test), as well as
reduced tyrosine hydroxylase activity in carotid bodies, revealed a
higher chemosensitivity to oxygen in transgenic mice. Moreover, in
line with the decreased activity of the rate-limiting enzyme for
dopamine synthesis, the intraperitoneal injection of a highly specific
peripheral ventilatory stimulant, domperidone, did not stimulate hy-
poxic ventilatory response in Tg6 mice. These results suggest that
high Epo plasma levels modulate the carotid body’s chemotransduc-
tion. All together, these findings are relevant for understanding the
cross-talk between the ventilatory and erythropoietic systems exposed
to hypoxia.
carotid body; brain stem; ventilatory control
UPON HYPOXIC EXPOSURE, ERYTHROPOIETIN (Epo) synthesis in kid-
ney is accelerated, resulting in augmented Epo plasma levels
and leading to enhanced hemoglobin synthesis and increased
hematocrit levels (10, 40). Epo also has several nonerythropoi-
etic functions (12). As such, Epo was recently identified as a
key factor controlling the hypoxic ventilatory response (HVR)
(39). We recently reported that Epo receptor (EpoR) is present
in peripheral chemoreceptors and central respiratory areas
controlling ventilation (V˙ E), including glomus cells in carotid
bodies (the primary sensory organ that monitors arterial oxy-
gen), NK-1R substance preceptor immunopositive neurons in
the pre-Bo¨tzinger complex (proposed as the generator of re-
spiratory rhythm), and the nucleus tractus solitarii in dorsal
brain stem (relays input from peripheral chemoreceptors to the
central respiratory areas) (39). Furthermore, it was demon-
strated that cerebrally produced Epo per se influences the
central respiratory activity, thereby increasing the respiratory
frequency (fR) in response to hypoxia. Recently, we demon-
strated that intracerebroventricular infusion of soluble EpoR, a
negative regulator of Epos binding to the EpoR, abolishes the
ventilatory acclimatization to chronic hypoxia (38).
Apart from enhancing V˙ E, erythrocytosis is also necessary to
increase oxygen-carrying capacity during exposure to chronic
hypoxia. As such, physiological erythrocytosis develops in
individuals living at a high altitude. Enhanced erythrocytosis is
also found in sports, the most prominent case being that of an
outstanding Olympic endurance athlete (19) harboring an au-
tosomal dominant erythrocytosis (33) that resulted in hemato-
crit levels up to 68%. Despite these beneficial effects, eryth-
rocytosis may have a pathological impact. This occurs in
lowlanders as a consequence of numerous respiratory disorders
and in some highlanders when high altitude hypoxia patholog-
ically stimulates dramatic increases in hemoglobin resulting in
chronic mountain sickness (35). It is believed that CMS is the
consequence of a ventilatory deacclimatization to hypoxia,
leading to central hypoventilation, severe hypoxemia, in-
creased erythropoiesis, and excessive erythrocytosis (27, 35).
In turn, excessive erythrocytosis leads to life-threatening cya-
nosis, hyperemia, increased viscosity, thrombosis, and pulmo-
nary hypertension in humans and mouse (13, 27, 35, 43).
Because Epo and the adaptation to erythrocytosis are of general
interest in sport medicine and are significant factors concerning
life at high altitudes, we studied the normoxic and HVR in a
transgenic mice (Tg6) that due to constitutive overexpression
of human Epo in brain and lung (13) develop chronic eryth-
rocytosis (36, 44). Despite Tg6 mice showing hematocrit
values up to 80–90%, we found no differences in minute V˙ E
between Tg6 and control [wild-type (WT)] mice during acute
and chronic hypoxia. Nevertheless, Tg6 mice showed dramatic
changes in the ventilatory pattern with enlarged fR but de-
creased tidal volume (VT), both under acute and chronic
hypoxic conditions. These findings suggest that elevated Epo
levels in brain and blood are important factors regulating
oxygen homeostasis in conditions of restricted oxygen supply.
MATERIAL AND METHODS
Transgenic animals. The Epo-overexpressing transgenic mouse
line was generated by microinjection of human Epo cDNA driven
by the human platelet-derived growth factor (PDGF) B-chain
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promoter into the pronuclei of fertilized oocytes derived from
B6C3 hybrid mice (36). The resulting transgenic mouse line
TgN(PDGFBEPO)321ZbZ (Tg6) showed increased Epo levels in
plasma (12-fold compared with WT) and brain (26-fold compared
with WT), accompanied by a doubled hematocrit value (48). This
erythrocytic line was backcrossed to C57BL/6 mice for more than 12
generations by mating hemizygous males to WT C57BL/6 females.
Half of the offspring were hemizygous for the transgene, while the
other half were WT and thus were used as control animals. All
experiments were performed in 3- to 4-mo-old male mice. Animal
experimental protocols were approved by the Veterina¨rant des KF
Zu¨rich.
Ventilatory measurements by plethysmography. Respiration was
monitored by the whole body flow through plethysmography tech-
nique as previously described (39). Briefly, mice were placed in a
600-ml chamber continuously supplied with airflow at 0.7–0.8 l/min
using flow restrictors. V˙ E was calculated as the product of VT and fR
and normalized to 100 g body wt (i.e., ml min1 100 g1). As soon as
the animal was familiarized with the plethysmographic chamber (1 h),
measurements of baseline V˙ E (normoxia, 21% O2) and hypoxic V˙ E
were performed. Acute hypoxia was achieved by flushing air balanced
in N2 using a gas-mixing pump (Digamix type M302a-F; H.
Wo¨sthoff). The fraction of inspired O2 (FIO2) in the chamber was
gradually decreased from 21% to 10% O2 over 15 min. Respiratory
recordings at 10% O2 were performed for 20 min. The oxygen
concentration in the chamber was then further reduced to 6% over the
next 15 min and recordings were performed for 20 min in the more
hypoxic environment. At the end of each experiment, body weight
was routinely measured to express VT in milliliters per 100 g in body
temperature and pressure (saturated) conditions. fR was defined as
respirations per minute. Hemoglobin was quantified using standard
methodology, and body temperature in normoxia and hypoxia was
measured using a rectal thermocouple (Fluke). The same measure-
ments of V˙ E and temperature were performed in animals that previ-
ously were exposed to chronic hypoxia (see below).
Chronic exposure to hypoxia was performed as described by
Prabhakar and colleagues (20, 24). Briefly, mice were housed in a
homemade hypoxic chamber connected to a gas-mixing pump (Diga-
mix type M302 a-F; H. Wo¨sthoff). The chamber oxygen concentration
was gradually reduced from room air to 10% over 30 min and
maintained at 10% for 3 days. During this period, mice were allowed
free access to food and water. One hour after returning the mice to
room air, baseline V˙ E and HVR at 10% and 6% O2 were recorded by
plethysmography as described above.
To avoid any movement of the animals during the brief exposure to
100% O2, the hyperoxic test [Dejours test (7)] was performed in
anesthetized mice. Two minutes after injecting urethane solution (1.2
g/kg) mice showed regular V˙ E and normal fR. Baseline respiration
was recorded while animals breathed 21% O2 for 20 s. The plethys-
mographic chamber was then quickly saturated with 100% O2, and the
decline of V˙ E was recorded over 20 s. Respiratory variables were
analyzed, and the magnitude of the transient V˙ E decline was calcu-
lated as the difference between baseline and hyperoxic respiration
parameters.
Baseline V˙ E in normoxia and V˙ E response to hypoxia (10% and 6%
O2) were evaluated 1–2 h after injection of domperidone (1 mg/kg ip;
kindly provided by Janssen-Cilag; dissolved in 0.9% saline solution
with 1 equivalent of tartaric acid). Note that according to the provider,
domperidone is a highly specific peripheral D2-dopaminergic receptor
agonist that does not cross the blood-brain barrier. Control animals
were injected with similar volumes of 0.9% NaCl.
An open-circuit system allowed measurement of O2 consumption
(V˙ O2, ml min1 100 g1; atmospheric temperature and pressure in
dry air) and CO2 production (V˙ CO2, ml min1 100 g1) in normoxia
and hypoxia (10% and 6% O2). Mice were placed in a chamber where
a steady 0.2 l/min flow of air was maintained. The fractions of O2 and
CO2 at the inflow and the outflow of the chamber were measured by
O2 and CO2 analyzers (Qubit Systems, Kingston, Ontario).
Quantitation of catecholamines in brain stem and carotid bodies.
Catecholaminergic cell groups were obtained from successive trans-
verse brain stem sections (60-m thick), according to a mouse brain
atlas (30) as described previously (47). In brief, A6 and A5 (in pons)
and A1C1 and A2C1 (in caudal region) were dissected from the brain
stem. Different animals were used to determine norepinephrine (NE)
content (in brain stem slices) or tyrosine hydroxylase (TH) activity (in
brain stem slices and in carotid bodies), the latter analysis requiring a
previous injection of 3-hydroxybenzylhydrazine dihydrochloride
(NSD 1015; 75 mg/kg ip in saline solution; Sigma, St. Louis, MO).
Twenty minutes after injection, animals were decapitated, and the
enzymatic activity of TH was indirectly evaluated by measuring the
accumulation of L-dihydroxyphenylalanine (L-DOPA) over 20 min,
following the blockade of L-DOPA decarboxylase with NSD 1015.
Both NE and L-DOPA were quantified by HPLC coupled with
electrochemical detection as described earlier (17). The mobile phase
consisted of 0.1 M potassium phosphate buffer pH 3.0 containing 0.15
mM disodic EDTA at a flow rate of 0.8 ml/min. L-DOPA was
measured at 0.65 V. The detection limit, calculated by doubling the
noise ratios and expressed in picomoles of injected amounts, was 
0.03 pmol, and the intra-assay coefficient was 0.2%.
Statistical analysis. Analysis was performed using the StatView
software (Abacus Concepts, Berkeley, CA). The reported values are
means  SD. For simple measurements, data were analyzed by
one-way ANOVA followed by a post hoc protected least significant
difference Fisher test. For hypoxic V˙ E responses, data were analyzed
by two-way ANOVA for repeated measurements. Differences were
considered significant at P  0.05.
RESULTS
Basal V˙ E and metabolic parameters showed no differences
in transgenic and WT mice. Minute V˙ E, fR, and VT, as well as
rectal temperature and metabolic variables, were evaluated in
transgenic Tg6 and WT control mice under basal resting
conditions (normoxia, 21% O2; Table 1). Neither the minute
V˙ E nor the ventilatory pattern, i.e., VT and fR were found to be
different between the two strains in a normoxic environment.
Additionally, no differences were noticed in metabolic param-
eters, such as body temperature, oxygen consumption, or
carbon dioxide production (Table 1 and Fig. 1, F–H, 21% O2).
Tg6 mice show higher fR but lower VT upon exposure to
acute hypoxia. The first attempt to regulate oxygen homeosta-
sis during hypoxia is hyperventilation (31). We measured the
V˙ E response in unanesthetized WT and transgenic mice to two
levels of normobaric hypoxia (10% O2 and 6% O2). HVR was
similar between WT and transgenic male mice (Fig. 1A).
However, the V˙ E pattern of Tg6 mice was substantially af-
fected; while fR of moderate (10% O2) and severe hypoxia (6%
O2) were significantly augmented (Fig. 1B; P  0.0001), VT
was extensively decreased (Fig. 1C; P  0.001). The compar-
ison of the relative proportions of fR and VT in the HVR
clearly shows that VT is the main contributor in the hypoxic
response of WT mice during hypoxia (Fig. 1D). On the
contrary, the fR is the major provider for the HVR in trans-
genic animals (Fig. 1E). Under our experimental conditions,
body temperature, oxygen consumption, or carbon dioxide
production (Fig. 1, F–H) were similar, thus the change in the
metabolic drive cannot account for the observed changes in
breathing pattern.
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Transgenic mice show altered breathing patterns after ac-
climatization to hypoxia. Long-term hypoxic exposure leads to
a progressive increase in minute V˙ E that is termed ventilatory
acclimatization to hypoxia (32). In mice this process is com-
pleted after 3 days (24, 29). Accordingly, transgenic and WT
control mice were exposed to 10% O2 for 3 days, and then
returned to normoxia to evaluate V˙ E during normoxia and acute
hypoxia. Both transgenic and WT mice showed similar in-
creases in the level of V˙ E during normoxia, indicating that
ventilatory acclimatization to hypoxia occurred (Table 1 and
Fig. 2, F–H, 21% O2). During the hypoxic challenges, Tg6 and
WT mice exhibited similar minute V˙ E (Fig. 2A), but show
differences in terms of hypoxic V˙ E pattern. In agreement with
the measurements performed under acute hypoxic conditions,
Tg6 mice showed higher fR (Fig. 2B) and lower VT (Fig. 2C)
responses to hypoxia compared with WT control animals. The
comparison of the relative proportions of fR and VT in the
HVR show that after chronic hypoxia in both WT and Tg6
mice, HVR is mainly supported by VT rather than fR; how-
ever, the contribution of VT to WT ventilatory response is
higher in WT compared with transgenic mice (Fig. 2, D and E).
As observed previously, alteration in body temperature or
metabolic rate (Fig. 2, F–H) did not change and thus cannot
account for the observed alterations in the V˙ E pattern.
Transgenic animals had altered catecholaminergic brain
stem levels. We recently reported that the overexpression of
Epo in neuronal cells alter catecholamine activity in respiratory-
related brain stem areas (39). In that work, we also showed the
presence of EpoRs on brain stem catecholamine neurons in WT
mice. Because the Tg6 mouse line overexpresses 26-fold more
Epo in brain compared with WT, we hypothesized that these
animals would exhibit an altered level of catecholamines in the
brain stem respiratory areas, which could contribute to the
observed changes in V˙ E. Our previous work strongly suggested
that Epo stimulation of fR during hypoxia is, at least in part,
mediated by an effect on catecholaminergic synthesis in the
brain stem (39). Thus, we evaluated TH activity and the NE
content in pontial A6 and A5 and medullar A1C1 and A2C2
brain stem catecholaminergic groups. Compared with WT
mice, we found that transgenic Tg6 animals showed higher TH
activity and NE content in A5 cell group only (Fig. 3B). In
contrast, the catecholamine synthesis in A6, A1C1, and A2C2
cell groups showed no differences in either mouse lines (Fig. 3,
A, C, and D). Knowing that increased catecholamine levels in
pontial groups contribute to augmentation of respiratory rate
during hypoxia (8, 14), our observations suggest that the
elevated fR observed in Tg6 mice during acute and after
chronic hypoxia is mediated by elevated cerebral Epo levels
that in turn modulate the synthesis rate of NE in brain stem
catecholaminergic A5 cells. Since previous publications
showed that catecholamines modulate V˙ E under normoxic as
well as hypoxic conditions (14, 15), the present data suggest
that the altered levels of catecholamines in brain stem respira-
tory areas contribute to the observed changes in fR and VT
during acute and chronic hypoxic V˙ E.
Tg6 mice exhibit higher peripheral chemosensitivity to
oxygen. The basal contribution of peripheral chemoreceptors to
resting minute V˙ E and carotid body sensitivity is in agreement
with the magnitude of the transient V˙ E decline in response to a
brief period of hyperoxia (Dejours test). We have previously
described the presence of EpoRs on carotid body cells in WT
mice (39). Thus, in anesthetized WT and Tg6 mice, we re-
corded the V˙ E during normoxia (during 20 s) and after a sudden
exposure to hyperoxia (100% O2) of a further 20-s period. The
hyperoxia-induced ventilatory decline was doubled in Tg6
mice compared with corresponding WT mice (Fig. 4A). In Tg6
animals, the ventilatory difference was mainly due to a higher
decline of fR rather than VT (Fig. 4, B and C). In parallel, and
considering that Epo is a potent factor modulating release of
catecholamines in cells with neural characteristics including
PC12 cells (22, 26, 41, 49), we also have evaluated TH activity
in carotid bodies of WT and Tg6 mice. Tg6 mice showed
significantly reduced TH activity compared with control WT
animals (Fig. 4D). As TH is the rate-limiting enzyme for
dopamine synthesis in carotid bodies, this data suggests that
inhibitory dopaminergic influences are reduced in Tg6 mice.
Altogether, these results imply that the Epo-mediated activa-
tion of carotid bodies against changes in arterial oxygen pres-
sure is higher in transgenic mice compared with WT.
Intraperitoneal injection of domperidone does not stimulate
HVR in Tg6 mice. Domperidone is a highly specific peripheral
D2-dopaminergic receptor-antagonist that causes a potent stim-
ulation of V˙ E and carotid sinus nerve discharge (16, 18). When
domperidone was injected into mice, we found that normoxic
(21% O2) and hypoxic (10 and 6% O2) V˙ E were stimulated in
WT animals (Fig. 5, A–C). However, consistent with the
reduced TH activity, this drug had no effect on normoxic or
hypoxic V˙ E of transgenic animals (Fig. 5, D–F). This result
suggests that the basic neurochemistry of the peripheral che-
moreceptor is altered in Tg6 animals and that high Epo plasma
levels are implicated in this chemosensory rearrangement.
Table 1. Metabolic parameters
Normoxia Normoxia After Chronic Hypoxia
Type of mice WT Tg6 WT Tg6
Number of mice used 10 9 10 8
Body weight, g 27.91.71 26.32.03 26.20.68 25.70.97
Body temperature, °C 37.70.67 36.70.23 37.40.95 36.30.71
Hemoglobin, g/dl 13.80.80 24.75.15 19.60.8 24.29.02
V˙ E, ml  min1  100 g1 86.54.69 93.57.09 117.26.35 120.89.92
fR, resp/min 143.18.60 157.74.80 165.19.94 173.85.81
VT, ml/100 g 0.610.02 0.590.4 0.720.03 0.690.05
V˙ O2, ml  min1  100 g1 10.20.79 9.50.61 17.51.80 17.82.01
V˙ CO2, ml  min1  100 g1 9.30.58 8.70.78 14.21.72 15.12.09
WT, wild-type mice; Tg6, transgenic mouse line TgN(PDGFBEPO)321ZbZ; V˙ E, ventilation; VT, tidal volume; fR, respiratory frequency; V˙ O2, O2
consumption; V˙ CO2, CO2 production.
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DISCUSSION
In the present study, the impact of high Epo levels and
excessive erythrocytosis on respiratory responses and ventila-
tory acclimatization to hypoxia were examined. We used a
transgenic mouse line showing constitutive high levels of
human Epo in brain (26-fold/WT) and plasma (12-fold/WT).
The hematocrit values of these mice was 80–90% (36, 43, 44).
Despite these remarkable characteristics, our results showed
that normoxic and hypoxic V˙ E in transgenic mice were similar
to WT control. Tg6 mice however, showed marked alteration
in the ventilatory pattern upon hypoxic exposure. fR in Tg6
mice was significantly higher, while VT decreased. In line with
earlier work, our results suggest that the elevated cerebral Epo
levels enhance fR in hypoxia and that Epo plasma levels
participate in the modulation of the carotid body chemotrans-
duction.
Following our previously published methodology (39), our
experimental protocol included ventilatory measurements dur-
ing normoxia, moderate hypoxia (10% O2), and severe hypoxia
(6% O2). These experiments were conducted in unanesthetized
and unrestrained mice. The advantage of this protocol is that it
alleviated the effects that anesthesia may have had on breathing
and allowed us to monitor changes in body metabolism that are
known to occur during hypoxia (21, 24, 38). Changes in blood
Fig. 1. Ventilatory (V˙ E) response to acute hypoxia in wild-type (Wt) and transgenic (Tg6) male mice. Hypoxia was achieved in 2 steps of 15-min gradual
reduction of fraction of inspired oxygen (FIO2) (represented by a black triangle); first step from 21% to 10% O2, and second step from 10% to 6% O2. V˙ E,
respiratory frequency (fR), and tidal volume (VT) were evaluated in Wt control and Tg6 mice over 20 min at 10% and at 6% O2 (A–C). The relative mean
proportions of fR and VT in the ventilatory response to hypoxia were calculated and are represented in the bars; since VT is the major component in Wt
ventilatory response, transgenic V˙ E is mainly supported by fR (D and E). Metabolic parameters; body temperature (F), V˙ O2 (G) and V˙ CO2 (H) were also
determined in Wt and Tg6 mice. *P  0.0001. Data are means  SD for n  10 animals per group.
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pressure and arterial gases could not be monitored in unanes-
thetized mice; nevertheless V˙ O2 and V˙ CO2 were evaluated. V˙ O2
and V˙ CO2 values, together with the V˙ E data, gave a reliable
indication of potential differences between the tested groups.
Considering, for example, that arterial CO2 pressure is propor-
tional to the metabolic rate and inversely proportional to V˙ E,
our results imply that arterial blood gases in normoxia and
hypoxia were similar between both mouse groups.
Compared with WT mice, minute V˙ E under normoxia, as
well as the HVR, during acute and after chronic hypoxia was
not altered in Tg6 mice. What triggers the neural control of V˙ E
in Tg6 mice–high Epo levels in brain and circulation or the
elevated hemoglobin concentration? A direct impact of hemat-
ocrit on the neural control of V˙ E has not been reported so far.
As blood viscosity rose exponentially with the augmentation of
hematocrit (6), we expected an exponential increase of pulmo-
nary vascular resistance (28). Interestingly, however, despite
hematocrit values of 80%, blood pressure, heart rate, and
cardiac output in Tg6 mice were not abnormal (36). As shown
earlier, the adaptive mechanisms to excessive erythrocytosis in
Tg6 mice involve increased activity of endothelial nitric oxide
(NO) synthase (eNOS). Thus, despite a concomitant increase
of the potent vasoconstrictor endothelin-1 (34), the eNOS-
mediated enhanced NO synthesis in Tg6 mice results in gen-
Fig. 2. Basal V˙ E and V˙ E response to hypoxia measured in Wt and Tg6 mice acclimatized to chronic hypoxia (3 days at 10% O2). After acclimatization to hypoxia,
animals were returned to room air and basal V˙ E was evaluated. Hypoxia was achieved with a gradual reduction of FIO2 (black triangle); from 21% to 10% O2
(over 15 min) and from 10% to 6% O2 (over 15 min). Hypoxic ventilatory response (HVR) was evaluated during 20 min at 10% and at 6% O2 (A–C). The relative
mean proportions of fR and VT were calculated and represented in bars (D and E). After chronic hypoxic VT is the major component of HVR both in Wt and
Tg6 mice; however, VT contribution is higher in Wt compared with transgenics. Metabolic parameters; body temperature (F), V˙ O2 (G), and V˙ CO2 (H) were also
determined in Wt and Tg6 mice. *P  0.001. Data are means  SD for n  10 animals per group.
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eralized peripheral vasodilatation (36). In parallel, one should
keep in mind that elevation of the NO metabolism in the lung
was also found in Tibetans and Bolivian Aymara as adaptive
mechanism to hypoxia (2). Another adaptive mechanism to
excessive erythrocytosis that most probably contributes to
normal V˙ E in Tg6 mice is the subtle increase of blood viscosity
that is due to an increased flexibility of the transgenic eryth-
rocytes (5, 43). We also speculate that increased flexibility of
the red blood cells in Tg6 animals contributes to normal
oxygen uptake and delivery. As such, we observed no differ-
ences in V˙ O2 and V˙ CO2 between Tg6 and control WT mice.
Taken together, these observations do not support the notion
that elevated hematocrit level influences the neuronal regula-
tion of V˙ E.
On the other hand, despite no differences in minute V˙ E, the
ventilatory pattern was remarkably altered. While not signifi-
cant, somewhat higher fR and lower VT are already observed
under normoxic conditions, and hypoxia potentiated these
differences. During hypoxic V˙ E fR increased significantly,
while VT decreased. We reported earlier that cerebral Epo
enhanced fR under hypoxic conditions (39). We also showed
recently that bilateral transsection of carotid sinus nerve (che-
modenervation) in WT mice leads to dramatic respiratory
depression during hypoxia, but high levels of brain Epo main-
Fig. 3. In vivo tyrosine hydroxylase (TH) activity and norepinephrine (NE) levels in brain stem catecholaminergic cell groups (A1C1 and A2C2 in the medulla
oblongata; A5 and A6 in the pons) were determined by HPLC. TH activity is expressed as picomoles of L-dihydroxyphenylalanine (L-DOPA) formed in 20 min
following blockade of L-DOPA decarboxylase. Significant differences were found in the A5 cell group. *P  0.05; n  10–12 animals per group.
Fig. 4. Peripheral chemosensitivity to oxygen evaluated by a hyperoxic test and TH activity in carotid bodies. Ventilation (V˙ E), VT, and fR declined (transition
from 21% to 100% O2) in response to hyperoxic testing (Dejours test). The experiment was performed in urethane-anesthetized Wt and Tg6 mice. Tg6 mice were
more sensitive to hyperoxia. Data are means  SD for n  8 animals per group. *P  0.001. TH activity is expressed as picomoles of L-DOPA accumulated
in 20 min following blockade of L-DOPA decarboxylase using 3-hydroxybenzylhydrazine dihydrochloride (NSD 1015). Noradrenaline levels were determined
using HPLC coupled to electrochemical detection. *P  0.05. Data are means  SD for n  10–12 animals per group.
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tained fR despite the absence of signal information coming
from the peripheral chemoreceptors (39). Because Tg6 mice
also overexpress Epo in brain (26-fold/WT), it is tempting to
attribute the higher hypoxic fR to local presence of Epo in
brain. In addition, our previous results strongly suggested that
Epo increased fR by altering the activity in brain stem cat-
echolaminergic centers. High content of NE in A5 group cells
increases the hypoxic fR (8, 14). In line with these observa-
tions, we found that Tg6 mice showed significant increases of
TH activity and NE content in A5 cells compared with WT
control mice (Fig. 3B). In conclusion, the present results,
together with previous data (39), support the hypothesis that
increased cerebral Epo level modulates the catecholamine
synthesis in brain stem. Once exposed to hypoxia, this alter-
ation affects the ventilatory response via increasing the fR.
Despite the tight correlation between HVR and catecholamin-
ergic metabolism in brain stem, we do not discard other
possible mechanisms by which cerebral Epo modulates the
hypoxic V˙ E.
Apart from stimulating erythropoiesis (10, 40), plasma Epo
affects hypoxic V˙ E most probably by interacting with carotid
body glomus cells. Carotid bodies are the main peripheral
sensors responding to decreased oxygen content and mediate
the integrated cardiorespiratory responses to hypoxemia. We
demonstrated earlier that intravenous injection of recombinant
human Epo in WT mice induced a significant alteration in
breathing pattern in response to severe hypoxia (39). An
increased fR and a profoundly decreased VT, compared with
vehicle-injected mice, suggested that plasma Epo levels par-
ticipated in the breathing control. The present results using Tg6
mice support this hypothesis. Moreover, reduced activity of TH
(the rate-limiting enzyme for dopamine synthesis in carotid
bodies) in transgenic carotid bodies, suggest that the inhibitory
function of dopamine is reduced in transgenic animals. In line
with these results, we found that Tg6 mice exhibited a higher
peripheral chemosensitivity as indicated by the response to the
hyperoxic challenge (Dejours test). The greater ventilatory
decline observed during hyperoxia implies that transgenic
carotid bodies exert a stronger tonicity, and this effect is most
probably due to direct stimulation by plasma Epo.
Despite good correlations between elevated central and
plasma Epo levels and acute and chronic hypoxic breathing
patterns in Tg6 mice, we do not discard other factors that may
contribute to this process. Indeed, as mentioned earlier we
showed that as a consequence of excessive erythrocytosis, Tg6
animals elevate expression of eNOS by threefold (36). The
Fig. 5. V˙ E response in normoxia and acute hypoxia upon
intraperitoneal injection of domperidone. Basal V˙ E was evalu-
ated after 1–2 h after injection of domperidone. Hypoxia was
achieved with a gradual reduction of FIO2 (black triangle); from
21% to 10% O2 (over 15 min) and from 10% to 6% O2 (over 15
min). HVR was evaluated during 20 min at 10% and at 6% O2.
Control animals were injected with similar volume of 0.9%
NaCl solution. *P  0.001; n  7–8 animals per group.
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generalized vasodilatation produced by eNOS activity prevents
Tg6 animals from cardiovascular dysfunction, hypertension,
and thromboembolic complication (36). However, the eNOS-
mediated production of NO also impacts on the peripheral
respiratory centers in hypoxia (42, 45, 46). As such, our data do
not allow discrimination between the effect produced by NO
and plasma Epo. However, as Epo is a potent factor leading to
the release of catecholamines in PC12 cells, a reliable model of
peripheral chemosensitive cells (22, 26, 41, 49), it is reasonable
to suggest that Epo and not NO is the responsible factor of the
catecholamine alteration observed in carotid bodies. The com-
bined impact of Epo and NO in the peripheral respiratory
centers is a matter of current investigation.
Very recently, the specificity of the commercially available
anti-EpoR-antibodies has been challenged (11). As regarding
neuronal cells, however, we and others have described 1) the
presence of EpoR mRNA in the brain of several mammals,
including humans, by RT-PCR (3, 4, 9, 23, 25, 37); 2) the
presence of specific Epo binding sites in the brain by using
radiolabeled Epo (9); 3) the impact of Epo on PC12 cells (a
reliable cell model of peripheral chemosensitive cells) (1, 26,
41, 49); and 4) the inhibition of the ventilatory acclimatization
to chronic hypoxia in WT mice by intracerebroventicular
infusion of soluble EpoR (38). Thus, there is convincing
evidence that EpoR is expressed in neural cells.
In conclusion, the ventilatory response to acute and chronic
hypoxia remains similar between Tg6 and WT animals. In
contrast, the ventilatory pattern was significantly altered–fR
was widely increased and VT was extensively decreased in
Tg6 compared with WT mice. In line with previous findings,
our results imply that enhanced cerebral Epo levels stimulate
fR in response to hypoxia. On the other hand, the modulation
of the hypoxic ventilatory pattern in Tg6 carotid bodies might
be a consequence of several factors, among them the high Epo
plasma levels being a major player. These results support the
hypothesis that enhanced levels of cerebral and plasma Epo are
important factors in the regulation of oxygen homeostasis and,
moreover, might have decisive implications in the ventilatory
acclimatization and deacclimatization process to high altitude
hypoxia.
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